11.5 C
New York
Wednesday, February 8, 2023

Value Investing Philosophy And NextGen Healthcare Inc. (NASDAQ: NXGN)?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for NextGen Healthcare Inc. (NXGN) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $17.28. The NextGen Healthcare Inc. has recorded 4,519 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that NextGen Healthcare to Host Fiscal 2023 Third Quarter Results Conference Call on January 24.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Stocks Info

NXGN belongs to the Healthcare sector of the NASDAQ while operating in the Health Information Services industry. At the end of the last regular session, the stock closed at $17.28 and fluctuated between $17.49 as its day high and $17.11 as its day low. The current market capitalization of NextGen Healthcare Inc. is $1.16B. A total of 0.57 million shares were traded on the day, compared to an average of 714.16K shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, NXGN has seen 16 BUY and 26 SELL insider trades, representing the acquisition of 581,157 and the disposition of 256,995 shares. Over the last 12 months, there were 38 BUYs and 57 SELLs from insiders. Insiders purchased 837,542 shares during that period but sold 577,278.

In the most recent transaction, Metcalfe David A sold 32,372 shares of NXGN for 20.58 per share on Dec 01. After the transaction, the Chief Technology Officer now owns 161,179 company shares. In a previous transaction on Nov 08, Waters Mitchell sold 9,783 shares at 20.50 per share. NXGN shares that EVP, Commercial Growth owns now total 70,469.

Among the insiders who sold shares, Metcalfe David A disposed of 32,372 shares on Nov 01 at a per-share price of $20.00. This resulted in the Chief Technology Officer holding 178,984 shares of NXGN after the transaction. In another insider transaction, Waters Mitchell sold 3,889 shares at $20.00 per share on Oct 26. Company shares held by the EVP, Commercial Growth now total 62,725.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for NXGN in the last 3 months, the mean price target is $21.43 with high estimates of $26.00 and low estimates of $18.00. In terms of 52-week highs and lows, NXGN has a high of $21.99 and a low of $16.13.

As of this writing, NXGN has an earnings estimate of $0.28 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $0.3 per share and a lower estimate of $0.27.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 8 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NXGN is Overweight with a score of 3.33. A total of 2 analysts rated the stock as Buy while 0 rated it as Overweight while 5 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 1 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles